BLLN
BillionToOne, Inc. Class A Common StockNASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$3.95B
P/E Ratio
159.11
EPS
$0.54
Beta
—
52W High
$138.70
52W Low
$61.96
50-Day MA
$81.33
200-Day MA
$87.94
Dividend Yield
—
Profit Margin
7.02%
Forward P/E
—
PEG Ratio
—
About BillionToOne, Inc. Class A Common Stock
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company is headquartered in Menlo Park, California.
Fundamentals
| Revenue (TTM) | $354.54M |
| Gross Profit (TTM) | $249.58M |
| EBITDA | $43.03M |
| Operating Margin | 16.50% |
| Return on Equity | 8.73% |
| Return on Assets | 4.46% |
| Revenue/Share (TTM) | $14.31 |
| Book Value | $11.00 |
| Price-to-Book | 7.82 |
| Price-to-Sales (TTM) | 11.15 |
| EV/Revenue | 10.04 |
| EV/EBITDA | 84.51 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 83.80% |
| Shares Outstanding | $41.44M |
| Float | $23.17M |
| % Insiders | 46.83% |
| % Institutions | 38.30% |
Historical Volatility
HV 10-Day
107.83%
HV 20-Day
105.37%
HV 30-Day
92.75%
HV 60-Day
90.14%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($117.71 target)
2
Strong Buy4
Buy2
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026